Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vipadenant Dose Escalation in Early Parkinson's Disease
NCT00451815Phase 2Withdrawn
- Sponsor
- Biogen
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of vipadenant in Parkinson's disease (PD), sponsored by Biogen. Status: withdrawn.
02
Drugs
vipadenant
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00451815.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00451815.